Whole Exome Sequencing Market: Global Industry Analysis and Forecast to 2020
Whole exome sequencing is a technique used for strategically sequencing all the protein coding genes in a genome known as exon. There are around 1, 80,000 exons, which constitute about 1% of the human genome. Whole exome sequencing is widely used for identifying genetic variants responsible for diseases such as Miller Syndrome and Alzheimer’s disease. Low cost associated with the whole exome sequencing, as compared to the whole genome sequencing. The whole exome sequencing market is segmented on the basis of products and services into kits, systems and services. The whole exome sequencing market is segmented on the basis of application into personalized medicine, diagnostics, drug discovery and others. The whole exome sequencing market is segmented on the basis of end-user into hospitals and clinics, research centers, pharmaceuticals companies and others.
Whole exome sequencing is a technique used for strategically sequencing all the protein coding genes in a genome known as exon. There are around 1, 80,000 exons, which constitute about 1% of the human genome. Whole exome sequencing is widely used for identifying genetic variants responsible for diseases such as Miller Syndrome and Alzheimer’s disease. Low cost associated with the whole exome sequencing, as compared to the whole genome sequencing. The whole exome sequencing market is segmented on the basis of products and services into kits, systems and services. The whole exome sequencing market is segmented on the basis of application into personalized medicine, diagnostics, drug discovery and others. The whole exome sequencing market is segmented on the basis of end-user into hospitals and clinics, research centers, pharmaceuticals companies and others.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Whole</strong> <strong>Exome</strong> <strong>Sequencing</strong> <strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong> <strong>and</strong><br />
<strong>Forecast</strong> <strong>to</strong> <strong>2020</strong><br />
Persistence <strong>Market</strong> Research Released New <strong>Market</strong> Report on “<strong>Whole</strong> <strong>Exome</strong> <strong>Sequencing</strong><br />
<strong>Market</strong>: <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong> <strong>and</strong> <strong>Forecast</strong> <strong>to</strong> <strong>2020</strong>”.<br />
<strong>Whole</strong> exome sequencing is a technique used for strategically sequencing all the protein coding genes in<br />
a genome known as exon. There are around 1, 80,000 exons, which constitute about 1% of the human<br />
genome. <strong>Whole</strong> exome sequencing is widely used for identifying genetic variants responsible for diseases<br />
such as Miller Syndrome <strong>and</strong> Alzheimer’s disease. Low cost associated with the whole exome<br />
sequencing, as compared <strong>to</strong> the whole genome sequencing. The whole exome sequencing market is<br />
segmented on the basis of products <strong>and</strong> services in<strong>to</strong> kits, systems <strong>and</strong> services. The whole exome<br />
sequencing market is segmented on the basis of application in<strong>to</strong> personalized medicine, diagnostics, drug<br />
discovery <strong>and</strong> others. The whole exome sequencing market is segmented on the basis of end-user in<strong>to</strong><br />
hospitals <strong>and</strong> clinics, research centers, pharmaceuticals companies <strong>and</strong> others.<br />
Buy Full Report: http://www.persistencemarketresearch.com/market-research/whole-exomesequencing-market.asp<br />
North America represents the largest market for whole exome sequencing. Increasing use of whole<br />
exome sequencing for diagnosis of rare diseases <strong>and</strong> increasing awareness about whole exome<br />
sequencing technology with the large number of sequencing-related conferences <strong>and</strong> annual meetings<br />
hosted by the U.S. drives the whole exome sequencing market in the North America region. Europe<br />
represents the second largest market for whole exome sequencing. Huge investment in rare diseases<br />
research <strong>and</strong> increasing awareness about whole exome sequencing technology with the large number of<br />
sequencing-related conferences <strong>and</strong> annual meetings hosted by the Europe boost the whole exome<br />
sequencing market in the Europe. Asia-Pacific is expected <strong>to</strong> be the fastest growing market for whole<br />
exome sequencing. Regular government funding <strong>and</strong> large numbers of conferences related <strong>to</strong> whole<br />
exome sequencing technique are the major driving force for whole exome sequencing market in the Asia-<br />
Pacific region.<br />
The low cost <strong>and</strong> high speed associated with whole exome sequencing technology, technological<br />
advancement in the whole exome sequencing technique <strong>and</strong> global alliances amongst leading research<br />
institute are some of the major driving force for whole exome sequencing market. The need for skilled<br />
professionals <strong>and</strong> high instrument costs are the major fac<strong>to</strong>rs that are restraining the growth of whole<br />
exome sequencing market.<br />
The major companies operating in the whole exome sequencing market include Roche NimbleGen, Inc.,<br />
Illumina, Inc., BGI (Beijing Genomics Institute, China), Ambry Genetics, Sengenics, Knome, Inc.,<br />
GENEWIZ, Inc. <strong>and</strong> Eurofins Genomics, Inc.<br />
Persistence <strong>Market</strong> Research 2
Change language